Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.

Lamy, T; Michelet, C; Dauriac, C; Grulois, I; Donio, P Y; Le Prisé, P Y

Lamy, T; Michelet, C; Dauriac, C; Grulois, I; Donio, P Y; Le Prisé, P Y.

Affiliation

Lamy T; Service d'Hématologie Clinique, Centre Hospitalier de Rennes, France.

Acta Haematol ; 90(3): 109-13, 1993.

Article in En | MEDLINE | ID: mdl-8291367

Subject(s)

Bacterial Infections/prevention & control; Neutropenia/complications; Vancomycin/therapeutic use; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bacterial Infections/etiology; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms/drug therapy; Neutropenia/chemically induced; Prospective Studies; Treatment Outcome; Vancomycin/administration & dosage; Vancomycin/adverse effects

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Bacterial Infections / Vancomycin / Neutropenia Type of study: Clinical_trials / Etiology_studies / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 1993 Type: Article

Search on Google

XML

PubMed Links